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Abstract
Background: To track the HIV epidemic and responses to it, the World Health Organization recommends 10 global indicators
to collect information along the HIV care cascade. Patient diagnosis and medical record data, harnessed through case-based
surveillance (CBS), can be used to measure 8 of these. While many high burden countries have well-established systems for
monitoring patients on HIV treatment, few have formally adopted CBS.
Objective: In response to the need for improved strategic HIV information and to facilitate the development of CBS in
resource-limited countries, we aimed to conduct situational assessments of existing data collection systems in Tanzania, South
Africa, and Kenya.
Methods: We developed a standardized protocol and a modularized data collection tool to be adapted for the particular focus
of the assessments within each country. The three countries were selected based on their stage of readiness for CBS. The assessment
included three parts: a desk review of relevant materials on HIV surveillance and program monitoring, stakeholder meetings, and
site visits.
Results: In all three countries, routine HIV program monitoring is conducted, and information on new HIV diagnoses and
persons accessing HIV care and treatment services is collected. Key findings from the assessments included substantial stakeholder
support for the development of CBS, significant challenges in linking data within and between systems, data quality, the ability
to obtain data from multiple sources, and information technology infrastructure. Viral load testing capacity varied by country,
and vital registry data were not routinely linked to health systems to update medical records.
Conclusions: Our findings support the development of CBS systems to systematically capture routinely collected health data
to measure and monitor HIV epidemics and guide responses. Although there were wide variations in the systems examined, some
of the current program and patient monitoring systems can be adapted to function effectively for CBS, especially if supported by
an improved patient registration system with shared unique health identifiers.
(JMIR Public Health Surveill 2017;3(3):e44)   doi:10.2196/publichealth.7610
KEYWORDS
HIV; surveillance; case reports; continuum of care; epidemiologic surveillance
JMIR Public Health Surveill 2017 | vol. 3 | iss. 3 | e44 | p.1http://publichealth.jmir.org/2017/3/e44/
(page number not for citation purposes)
Harklerode et alJMIR PUBLIC HEALTH AND SURVEILLANCE
XSL•FO
RenderX
Introduction
The World Health Organization (WHO) released consolidated
guidelines in 2015 recommending ten global indicators to track
the HIV epidemic and responses to it and measure progress and
drive action toward the 90-90-90 targets of the United Nations
Joint Program on AIDS (UNAIDS) [1,2]. To provide
high-quality, timely, and reliable data by population
characteristics and across the different levels of a health care
system, it is recommended to develop a comprehensive strategic
HIV information system [2-7]. Case-based surveillance (CBS)
is such a system, and it is a key element of HIV Second
Generation Surveillance, which is recommended by the WHO
[8].
Case-based surveillance has three characteristics that
differentiate it from most HIV program monitoring systems.
The main distinctive characteristic is that at all levels (facility,
subnational, and national health agencies or ministries), CBS
systems obtain and retain individual-level data for each person
diagnosed with HIV. The second characteristic is within-system
record linkage that is facilitated by the collection of a unique
identification number (eg, a national or regional health care
identification number) or unique personal identifiers (eg, full
or part date of birth, sex, full or part name, and a marker of
residence). Individual record linkage at the national level enables
the identification and removal of duplicate records and the
tracking of cases over time, thereby providing a more accurate
number of cases than can be obtained through aggregate data
from facilities. The third characteristic is that CBS data are
gathered and retained from multiple data sources (eg, from
testing laboratories and facilities and from care facilities). This
aspect of CBS serves two important purposes: it improves the
completeness of case ascertainment, and it provides critical
information on the key events that concur with global indicators
[1]. These events include HIV diagnosis, entry into care,
initiation of antiretroviral therapy (ART), disease progression
or treatment success (as measured by CD4 (T-helper) cell and
viral load tests), and death.
By developing a linked database, CBS data can contribute
information to all but two (domestic finance and prevention by
key population) of the ten global indicators described in the
consolidated guidelines [1]. Table 1 presents how CBS data
may be utilized to measure the eight indicators [1].
Table 1. The use of case-based surveillance data in measuring indicators along the HIV care cascade.
CBSa dataIndicator
Directly provide national or regional specific estimates of people living with diagnosed HIV and indirectly provide
national or regional specific estimates of undiagnosed HIV by fitting statistical models to data (eg, back-calculation
analysis of CD4 count at the time of diagnosis)
People living with HIV
Indirectly provide estimate of denominator (all living with HIV) and directly provide estimate of numerator (cumulative
diagnoses minus deaths or number of people currently in care)
Knowing HIV status
Directly measured based on the report of a CD4 cell or viral load testLinkage to care
Indirectly provide estimate of denominator (all living with HIV) and directly provide estimate of numerator (number
of people currently on ART)
Currently on ARTb
Directly measure denominator (initiated ART) and numerator (number of people retained on ART according to an applied-
time criteria)
ART retention
Directly calculate denominator (on ART) and numerator (virally suppressed)Viral suppression
Directly measure through reporting (the provision of data from source) and follow-up of cases, and indirectly measure
through linkage with vital statistics for deaths and cause of death
AIDS deaths
Provide a framework for conducting recency testing or for incidence estimation through back-calculation analysis of
CD4 count at the time of diagnosis
New HIV infections
aCBS: case-based surveillance.
bART: antiretroviral therapy.
Although HIV CBS is conducted in many high, middle, and
low income countries, it has not been implemented in
sub-Saharan Africa, where the burden of the disease has been
greatest [9]. In an environment where donors are increasingly
insisting on cost-sharing assurances from the governments of
low- and middle-income countries, and for more cost-effective
use of funds [1], HIV CBS presents a cost-effective method for
collecting strategic information in sub-Saharan Africa to
improve patient and program management. To identify systems
that are context appropriate, feasible, scalable, and sustainable
for CBS, the Measurement and Surveillance of HIV Epidemics
(MeSH) Consortium facilitated situational assessments in
Tanzania, South Africa, and Kenya between August 2015 and
February 2016.
Methods
In our assessments, we focused on the feasibility of
implementing CBS, including the availability of individual-level
data, the ability to uniquely identify and link cases, and the
capacity to capture key events along the HIV care cascade from
multiple sources. We developed a protocol and data collection
tool to promote a standardized approach to our situational
assessments [10]. Our assessment included three parts: (1) desk
review of materials relevant for HIV surveillance, (2) meetings
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with stakeholders knowledgeable about HIV strategic
information, (3) site visits to understand human resource
capacity and the availability and quality of data. For the
meetings and site visits, the data collection tool was used and
notes were taken by between two and four assessors while
on-site. In Kenya and South Africa, all meetings were conducted
in English. In Tanzania, the majority of the meetings where
conducted in English, with a couple conducted in Kiswahili
with the aid of a translator.
The data collection systems assessed include patient monitoring
systems (PMS), which maintain individual patient health
information at the facility, and laboratory information
management systems (LIMS), which maintain individual-level
data from laboratory tests. Information held by PMS may be
paper-based (consisting of a standard medical chart) or
electronic—referred to as an electronic medical record
(EMR)—and may be completed either by clinical or clerical
staff after clinical staff complete the paper records.
Our assessment team had experience in the implementation and
management of PMS and CBS systems and data. Prior to each
assessment, we met with national and international stakeholders
to confirm the focus of the appraisal, to develop a list of
documents to obtain and review (eg, on policies concerning
disease reporting, medical record privacy, and data security),
to identify further relevant stakeholders for engagement, and to
agree on sites to visit.
Kenya, Tanzania, and South Africa were selected for assessment
based on having high HIV prevalence, partial or fully
implemented electronic data systems, and being a MeSH
Consortium focus country. The focus of our assessment differed
in each country (see below). In all 3 countries, there was
engagement with regional and national stakeholders, including
Ministry of Health representatives, and results with
recommendations were presented back to stakeholders in the
form of a country specific detailed assessment report.
In Tanzania, we assessed the feasibility and acceptability of
developing a HIV CBS system. As the HIV care and treatment
clinic (CTC) PMS has greatest coverage of individual-level data
in Tanzania, the system was a major focus of our assessment.
To include both urban and rural areas with substantial disease
burden, the assessment was conducted in the Dar-es-Salaam
and Mwanza regions. Site visits were made to nine health
facilities and laboratories providing HIV services in these areas
at various levels (regional and district hospitals, health centers,
and dispensaries). A total of 23 stakeholders were engaged with
at the national, regional, district, and facility levels.
Our assessment in South Africa considered how existing
multi-facility-based integrated HIV data systems and various
patient identifiers could be used for CBS. We focused on the
Three Interlinked Electronic Registers system (TIER.Net) and
the National Health Laboratory System (NHLS). The Western
Cape Province was selected as a region where the TIER.Net
system and identifiers could be explored. The NHLS is based
in Johannesburg. Seven stakeholders were engaged at the
national and regional (Western Cape) level and two health
facilities offering HIV care and treatment and one regional
laboratory were visited.
In Kenya, in 2015, a pilot of CBS was performed in a
high-burden region in order to inform the development and
implementation of a national CBS system. Cases were identified
and reported by surveillance officers and by facility staff who
received a monetary stipend for their CBS work. Among other
findings, the human resource costs associated with the pilot
methods called into question the sustainability of this CBS
model. The goal of our assessment was to explore reporting
options that might be less demanding of human resources. In
Nairobi and Kisumu counties, we examined the potential for
reporting from EMRs, laboratories, and providers (clinical and
HIV testing counselors) without additional compensation and
met with six national and regional stakeholders. We also visited
three regional laboratories and 8 health facilities at various levels
(sub-district hospitals, health centers, and dispensaries).
We present results and recommendations from the three
components of our assessments in each country and by a
framework based on the three distinctive characteristics of CBS.
In addition, we assess the commonalities and differences in the
ability of the three countries to measure the care cascade
indicators and the feasibility of implementing CBS under current
conditions.
Results
United Republic of Tanzania
Collecting Individual-Level Data
Currently, in Tanzania, the most comprehensive mechanism for
reporting clinical HIV data is aggregate reporting of routine
program monitoring activities to the District Health Information
System (DHIS-2). In addition to this, HIV programs led by the
Ministry of Health and Social Welfare (MoHSW) have their
own reporting mechanisms. Primary among these is the HIV
CTC program, which is the PMS for HIV care and treatment
that collects individual-level data for both adult and pediatric
cases. At the time of the assessment, 637 CTC sites reported
individual-level data to the national CTC system, providing
information on 67% of all persons receiving ART [11].
Uniquely Identifying and Linking Records
Names are collected when patients enter HIV care, but are not
made available outside of a health facility. Names are not
universally collected at HIV testing and counseling (HTC)
facilities. The recording of names of persons receiving HTC
services in a paper registry was observed at one facility, although
the purpose of this was not clear. While information on age and
sex are collected at testing and care facilities, the absence of
names at testing sites presents challenges for linking records to
obtain an accurate estimate of the number of people diagnosed
or to monitor linkage to care.
Each CTC facility records personal identifiable information and
assigns a unique number to new attendees, thereby facilitating
within-site data linkage. Although this CTC number is unique
within the country, it is often not transferred from one facility
to the next, resulting in patients being assigned an additional
number when obtaining care at a subsequent CTC site. Multiple
assignments of CTC numbers, coupled with the absence of a
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national identifier in Tanzania, make data linkage between sites
to monitor individuals who receive care at two or more sites
consecutively or over time, challenging.
Capturing Key Events From Multiple Data Sources
A number of variables required for CBS to produce key
indicators along the care cascade are available through the CTC.
These include the number of patients in care, the number of
patients on ART, and ART retention. As identifying data are
not routinely collected at HTC facilities, individual-level data
are only captured for those who seek care. Tanzania has not yet
adopted routine viral load monitoring for patients on ART.
Most CTC facilities enter data into an electronic database.
However, various information technology issues were observed,
including smaller facilities not having computers, inconsistent
connectivity and power outages, and a lack of interoperability
between the PMS and other data systems at the health facility.
It is likely that the observed shortcomings of the health facility
staff members in the area of information technology
compromises the completeness and quality of the data. Neither
new diagnoses nor vital statistics data are linked with CTC data,
and although regional laboratories and pharmacies have
electronic information systems, they also are not linked to the
CTC system.
Feasibility and Readiness of Implementing Case-Based
Surveillance
The CTC system currently performs several of the functions of
CBS, collecting individual-level data from point of entry into
care on approximately two-thirds of persons on ART in
Tanzania. To move toward a comprehensive system for CBS,
CTC data would need to be routinely and accurately linked
across CTC and non-CTC facilities, HTC programs, and vital
statistics.
The situational assessment found that CBS implementation
would put pressure on resources and staff time and would
potentially undermine clinical care and data quality if there were
additional data collection requirements. Current data quality
was a concern, as data quality assurance (DQA) through
availability of, and adherence to, standard operational
procedures, is not enforced, and there is limited use of data
beyond mandated program reporting.
Republic of South Africa
Collecting Individual-Level Data
South Africa has implemented a national PMS that captures
longitudinal information on persons on ART. The system,
entitled TIER.Net, collects individual-level data at the facility
level that are then reported nationally, including patient names
and other personal identifiers. Although TIER.Net has modules
for HIV testing and pre-ART care, neither was in operation in
the places we assessed. Reportedly, these modules are used by
some jurisdictions.
In South Africa, HIV testing is based on a point-of-care
rapid-testing algorithm, with only discordant findings sent to a
laboratory for confirmation. Health facilities do, however, use
a robust and reliable transport system to routinely send
specimens to regional laboratories for CD4 cell counts, viral
loads, early infant diagnosis, full blood counts, and blood
chemistry. As part of the NHLS, the national laboratory data
warehouse has available all CD4 cell count and viral load tests
from persons receiving HIV care in the public sector. The NHLS
provides services to over 80% of the population (and a higher
percentage of those living with HIV) through a national network
of laboratories that use a LIMS to capture and centralize
individual-level data for both adult and pediatric patients.
Other individual-level data sources are available nationally and
regionally. In the Western Cape, individual-level data on hospital
admissions, ambulatory visits, and medicine dispensing are
accessible to government health services with varying
completeness. Vital registration systems are well established in
South Africa, with 96% of HIV deaths estimated to be recorded
in a national population register [12]. These data, however, are
no longer routinely available to health services as death
certificates are now sealed and managed by other government
departments after completion by health practitioners.
Uniquely Identifying and Linking Records
There are a number of distinct personal identifiers, HIV-specific
and general, in use in South Africa. Health services issue
medical record numbers that are unique to each facility. The
national civil identifier is available to all citizens and is currently
recorded as an identifier when patients register for health
services. However, approximately 10% of the South African
population are non-citizens and, therefore, are not assigned this
identifier. Moreover, a substantial proportion of citizens have
historically not presented their civil identification documents
when availing themselves of services. A national health patient
registration system is currently being developed, in which every
patient will be eligible.
Recognizing the limitations of the national civil identifier and
facility medical record numbers for resolving the issue of
duplication of cases for surveillance purposes, the NHLS data
warehouse considers name and date of birth alongside this
identifier to distinguish unique individuals. The NHLS also
includes barcodes that can be scanned for each test that uniquely
identify the patient specimens and assist with resolving
duplication issues and establishing the data quality of identifiers.
Patient master indexes are in use in some areas to identify and
resolve duplication of records pertaining to a single patient. For
example, in the Western Cape Province, a patient master index
has enabled linkage of laboratory, pharmacy, and service data
in a data center environment that meets the key requirements
of CBS.
Capturing Key Events From Multiple Data Sources
The variables required by CBS to produce a number of the
indicators along the care cascade are available. The PMS can
be used to identify the number of patients on ART, ART
retention, and viral suppression. Viral load and CD4 testing is
standard for ART patients and is performed at centralized
laboratories using the same national LIMS. Having been
de-duplicated, the NHLS uses CD4 test data to estimate the
number of persons in care and viral load test data to estimate
the number of persons on ART and to measure viral suppression.
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The number of persons newly diagnosed with HIV is only
captured in registers at health facilities, as diagnosis is done by
rapid testing.
Feasibility and Readiness of Implementing Case-Based
Surveillance
Both the PMS and NHLS LIMS perform several of the functions
of CBS, collecting individual-level data and routinely
de-duplicating these data at the provincial and national level.
To build a CBS system based on these systems, all point-of-care
test results (not only discordant test results) will require to be
digitalized for entry into the LIMS. To comprehensively describe
the care pathway, data from vital statistics programs will also
need to be routinely linked to these data. A CBS system built
on laboratory and patient information systems would obviate
the need for developing a formal notification process for
surveillance purposes, an activity that has historically failed in
South Africa.
The PMS has staff shortages and facility service pressures that
could compromise adherence to standard operating procedures
and, therefore, data completeness and quality. There is a backlog
of laboratory results to be filed in medical charts in many
facilities, resulting in incomplete laboratory data being reported
through the PMS.
Republic of Kenya
Collecting Individual-Level Data
Multiple data systems exist in Kenya from which
individual-level data for HIV CBS can be obtained. Information
on new HIV diagnoses for both adult and pediatric cases is
captured in paper registers at health facilities. Individual-level
HIV care and treatment data are collected at facilities using
standard Ministry of Health forms and registers, although the
data are reported in aggregate at the national level. In the
majority of the large HIV care facilities (>500 patients), EMRs
have been implemented. Facilities with EMRs report quarterly
to a data warehouse that was developed in 2015. At the time of
the assessment, 347 (52%) of the EMR facilities were reporting
data to the warehouse. There are also seven regional laboratories
that conduct viral load and early infant diagnostic tests, all using
a LIMS to capture patient-level data.
Existing infrastructure presents challenges to capturing and
storing individual-level data electronically. All visited facilities
reported having experienced periodic power outages, and only
larger facilities reported having backup generators.
Uniquely Identifying and Linking Records
Adults (aged ≥18 years) are provided a unique national civil
identification number. Although these numbers are currently
not collected as part of routine health care, registers have
recently been modified by the Ministry of Health to facilitate
collection. Nationally, patient names (first, middle, and last
names) and age are collected as identifiers in HTCs for all
patients. All patients in care are assigned a unique number that
is included in the PMS, regional LIMS, and EMR data
warehouse. Although this number is unique within the country,
it is often not transferred from one facility to the next, resulting
in patients being assigned an additional number when obtaining
care at a subsequent site. Names are not recorded at six of the
seven regional laboratories, nor are they recorded at the EMR
data warehouse. The lack of identifiers limits the accuracy of
data matching and de-duplication processes.
Capturing Key Events From Multiple Data Sources
A high number of variables necessary for CBS are available in
Kenya. The national PMS can be used to identify the number
of patients in care, on ART, retained on ART, and achieving
viral suppression, although many of the facilities use
paper-based systems. The EMR data warehouse obtains the
same variables as the PMS but is limited to facilities with an
EMR. Interoperability between EMRs is currently not available
as the systems have different software developers and are not
designed to be networked.
Viral load testing is standard for ART patients and is performed
at centralized laboratories using a LIMS, with results reported
to care and treatment facilities. However, the time from
obtaining the specimen to the availability of the result varies
and can exceed the target of two weeks. In one laboratory, as a
result of reagent stock outs, this time period exceeded six
months.
A notable high-quality system is the Eastern Deanery AIDS
Relief Program (EDARP), which operates fourteen health
facilities. They have developed a fully integrated, networked,
and paperless EMR system, which includes a LIMS and
pharmacy system. Patients are entered into the EMR when they
come to HTCs, allowing for tracking of patients from diagnosis
into care. The system collects several identifiers, including the
national identity number. It is a closed (self-contained) system
that requires sustainable resources, and it highlights what can
be achieved should resources be available.
Feasibility and Readiness of Implementing Case-Based
Surveillance
The EMR data warehouse and LIMS systems are currently not
sufficient for CBS, as names and national identifier are not
included. Additionally, the data in the EMRs are not
systematically compared against the paper medical records to
assess accuracy of data entry. Limitations of the PMS for CBS
are that for nearly all facilities, recording of data begins at entry
to care, does not link to information on HIV diagnoses or vital
registrations, and are often paper-based. Current demands on
providers for patient management preclude the possibility of
reporting patients for CBS, although HTC counselors could
potentially report new diagnoses if variables are minimal.
Commonalities and Differences across the Three
Countries
Stakeholders in the three countries indicated substantial interest
in, and support for, CBS to effectively monitor HIV. In all three
countries, routine HIV program monitoring is conducted,
registers and paper medical records are standardized, and
variables collected are sufficient for CBS. There are efforts in
South Africa and Kenya to establish national data warehouses
with individual-level data.
Stakeholders expressed concern over resources, indicating that
CBS would only be feasible and sustainable if it could be
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conducted without substantially increasing the workloads of
health care providers and surveillance officers. Based on current
reporting requirements, stakeholders felt that having sites report
data through their existing electronic systems (EMRs and LIMS)
would not require substantial additions to facility level staff but
would require additional training and information technology
support.
Implementing CBS based on current systems would result in
gaps between care cascade indicators due to the absence of
linkage between testing, care, and mortality data. Currently
systems for testing and deaths are primarily paper-based with
limited identifiers and are not routinely linked to health systems.
Cascade of care data availability are presented in Table 2 [1].
Although EMRs are in place in each of the three countries, they
vary in design, quality, and coverage of facilities. Unstable
power sources and internet access was a problem often cited as
it adversely impacted electronic and networked systems. Also
often cited was the issue of poor data quality and difficulties in
comprehensively collecting accurate personal identifying
information. These and additional factors affecting the feasibility
of CBS are presented in Table 3 [13].
Table 2. Data availability for care cascade indicators.
KenyaSouth AfricaTanzaniaCascade measure
Testing data are in paper-based regis-
ters and include names and other per-
sonal identifiers, although data are not
sufficient for de-duplication issues. The
PMS includes date of diagnosis.
Testing data are in paper-based regis-
ters and include names and other per-
sonal identifiers that may be used for
de-duplication issues. The PMS in-
cludes date of diagnosis.
Testing data are in paper-based regis-
ters but do not include names or other
personal identifiers needed for de-dupli-
cation issues. The PMSa includes date
of diagnosis.
People living with HIV
diagnosed
Insufficient identifiers obtained in test-
ing to unduplicate and determine pro-
portion linked to care. The PMS starts
at entry to care.
The PMS does not currently include
care information prior to starting ARTb.
Care services are sometimes offered
separately from ART services.
Unable to determine unduplicated
number of people diagnosed; therefore,
the proportion of people linked to care
cannot be determined. The PMS starts
at entry to care.
HIV care coverage
Only the proportion of people in care
on ART can be determined.
Only the proportion of people in care
on ART can be determined.
Only the proportion of people in care
on ART can be determined.
ART coverage
Can be determined at the facility level;
currently unable to resolve duplication
issues at the national level.
Can be determined through viral load
tests noted in the PMS and LIMSc.
Can be determined at the facility level;
currently unable to resolve duplication
issues at the national level.
ART retention
Viral load testing for routine monitor-
ing of persons on ART is fairly recent;
data are available in the LIMS and
there is often a long lag time between
tests and data entered into the PMS.
Viral load testing for routine monitor-
ing of patients on ART is widely
available. Test information is available
in the PMS and LIMS, typically within
48 hours.
Viral load testing for routine monitor-
ing of patients on ART is being rolled
out and is currently unavailable for
most patients; tests conducted are noted
in the PMS.
Viral suppression
Deaths are recorded in the PMS, al-
though reporting is incomplete, espe-
cially cause of death. The death registry
is a separate paper-based system and is
not routinely linked to the PMS.
Deaths are recorded in the PMS. The
death registry is a separate electronic
system with limited access by health
staff.
Deaths are recorded in the PMS, al-
though reporting is incomplete, espe-
cially cause of death. The death registry
is a separate paper-based system and is
not routinely linked to the PMS.
AIDS-related deathsd
aPMS: patient monitoring system.
bART: antiretroviral therapy.
cLIMS: laboratory information management system.
dThe ability to separately identify and report on AIDS-related deaths, as opposed to all-cause mortality amongst people living with HIV, was not assessed.
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Table 3. Factors affecting the feasibility of case-based surveillance.
KenyaSouth AfricaTanzaniaFactors
In a recent CBSd pilot, de-duplication
was performed using an algorithm. The
new EMRe data warehouse de-dupli-
cates data based on clinical identifier.
Limited DQA is being conducted at
facilities.
Roll out of a patient health registration
system with a unique identifier is in
progress. The NHLSb de-duplicates
data utilizing an algorithm.
DQA policies are in place and variably
implemented for the PMSc.
Currently de-duplication is performed
only by clinical identifier.
Although DQAa policies are in place,
they are not fully implemented.
Data management
Policies are in place for infectious dis-
ease reporting, but not specific to HIV.
There are gaps in policies for data secu-
rity, confidentiality, and purpose and
utilization of EMRs, LIMSf, and the
data warehouse.
There are no policies that mandate HIV
reporting. Policies are in place for data
quality, security, and routine program
data management. There is a policy
impasse around access by health depart-
ment to vital registration data.
There are no policies for HIV reporting,
data security, and confidentiality. Poli-
cies in place for data quality are often
not being followed.
Policies
Four main EMRs are operating at
health facilities. The EMRs are not in-
teroperable.
Backup of the data varies between facil-
ities.
The quality of data in EMR systems
has not been evaluated.
A system is in the pilot phase to pull
data from each type of EMR for CBS.
Internet connectivity is limited in rural
areas. Power outages are common;
larger health facilities have a generator.
TIER.Neth is a national system that
limits interoperability issues. It is imple-
mented off-line with quarterly dispatch-
es sent centrally.
The national LIMS captures the major-
ity of laboratory tests, which are then
checked for duplications.
Regional laboratories all utilize the
same LIMS to reduce interoperability
issues.
Internet connectivity is limited in rural
areas. Staff shortages impact the quality
of the implementation of the TIER.Net
system.
The majority of care facilities enter
data into an electronic database; the
database does not have connectivity
and data are extracted on a quarterly
basis and sent to the national level. The
PMS database is national; therefore,
interoperability is thought to be unnec-
essary.
Although there is a pharmacy module
in the CTCg system, it is rarely utilized.
Various LIMS exist although are not
connected to the CTC.
Internet connectivity limited in rural
areas.
Information technology
aDQA: data quality assurance.
bNHLS: National Health Laboratory System.
cPMS: patient monitoring system.
dCBS: case-based surveillance.
eEMR: electronic medical record.
fLIMS: laboratory information management system.
gCTC: care and treatment clinic.
hTIER.Net: Three Interlinked Electronic Registers.
Discussion
Principal Findings
The findings from the situational analyses support the
development of CBS systems. However, none of the programs
or PMS in their current forms can accurately monitor indicators
along the care cascade to track progress toward the UNAIDS
90-90-90 targets.
The lack of a universal patient unique identification system in
all three settings is the most important obstacle to the evolution
of existing systems, whether electronic or paper-based, toward
CBS because of its pivotal role in linking records across systems
and resolving duplication in reports. A robust CBS system
requires data collection systems that pertain to HIV infected
persons to collect patient names (or an anonymized
representation of their names) and a national identifier. A robust
system must also maintain data confidentiality and security.
Electronic medical records were present in all three settings,
and they hold the potential for efficient and secure collection
and transfer of data for CBS. However, investment in
infrastructure and information technology is necessary to expand
the use of EMRs to include information from HIV testing sites
and laboratories.
To promote the collection and use of individual-level data from
multiple sources through CBS, standard operating procedures
and national policies need to be developed. These policies and
procedures must address any legal requirements for disease
reporting and endorse data security and confidentiality. It has
been suggested that policies and procedures also engage civil
society in the development of identifiers, promote performance
standards for completeness, timeliness, and data quality, and
take into consideration discriminative laws and policies on HIV,
sex work, drug use, and same-sex relations [1,2,4,9].
Laboratory information management systems are increasingly
common, and in many settings, viral load testing at regional
laboratories is expanding, offering the potential for efficient
reporting of these tests and results. Developing laboratory data
are a key contributor to CBS goals. Countries should develop
a harmonization strategy for laboratory data that includes
comprehensive inclusion and sharing of available identifiers.
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The ability to retrieve system-wide laboratory data would
support the development of a CBS system; ideally, such a system
could also promote continuity of care as patients increasingly
move between health facilities.
In all settings, there was evidence of fragmentation of
information systems. Multiple systems, limited interoperability,
and inadequate capacity present barriers to managing the
complex functions of stewarding the information system and
the interoperability environment. To overcome these barriers,
national and subnational health ministries should be actively
capacitated to implement and sustain these functions for clinical
care, service management, and surveillance purposes. This
should include ensuring that available data, including vital
registration, be accessible to the health ministries.
Limitations
Due to practical limitations, we conducted our assessments only
in select regions within each of the three countries, and not all
stakeholders, such as the private sector, were included in the
assessment. As our aim was to assess whether existing data
systems could facilitate the development of CBS in
resource-limited countries, an evaluation of the data quality
within each system, the potential to capture information on key
populations, and the potential representativeness and timeliness
of a future functioning CBS system was not performed. Despite
these limitations, our findings indicate that with some important
changes and additions to existing systems, CBS can be
developed or strengthened in the three countries.
Conclusions
Evidence from several settings has demonstrated the ability of
CBS to systematically capture routinely collected health data
to describe and monitor HIV epidemics for program planning
and evaluation and, ultimately, disease control [14-17]. It is
likely that countries in sub-Saharan Africa, in addition to the
three assessed, have existing systems that may be improved and
expanded to accommodate CBS implementation. Considering
the characteristics that define CBS, these countries should
carefully examine and evaluate their existing infrastructure,
human resource capacity, HIV PMS, EMRs, and infectious
disease reporting systems and develop a CBS system that, to
the greatest extent possible, leverages current systems and staff.
In implementing HIV CBS, systems need to be developed so
that they are context appropriate, feasible, scalable, secure, and
importantly, given the resource environment, sustainable.
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